A clinical trial designed to show the efficacy of a new drug in reducing progression to hypertension reports the following data. Using this information, compute the relative risk of progression to hypertension among patients receiving the new drug as compared to the placebo.
New Drug
Placebo
Sample size
200
Progression to hypertension
14%
19%
Already registered? Login
Not Account? Sign up
Enter your email address to reset your password
Back to Login? Click here